Form 8-K - Current report:
SEC Accession No. 0001628280-25-009570
Filing Date
2025-03-04
Accepted
2025-03-03 19:16:18
Documents
16
Period of Report
2025-03-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K core-20250302.htm   iXBRL 8-K 44717
2 EX-99.1 ex991-cfotransition.htm EX-99.1 16545
3 cs_logoxhorizontal-color002a.jpg GRAPHIC 38646
  Complete submission text file 0001628280-25-009570.txt   303241

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT core-20250302.xsd EX-101.SCH 2904
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT core-20250302_def.xml EX-101.DEF 17006
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT core-20250302_lab.xml EX-101.LAB 30883
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT core-20250302_pre.xml EX-101.PRE 17864
19 EXTRACTED XBRL INSTANCE DOCUMENT core-20250302_htm.xml XML 5836
Mailing Address 838 WALKER ROAD SUITE 21-2105 DOVER DE 19904
Business Address 838 WALKER ROAD SUITE 21-2105 DOVER DE 19904 (425) 998-5300
Core Scientific, Inc./tx (Filer) CIK: 0001839341 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40046 | Film No.: 25700774
SIC: 6199 Finance Services
(CF Office: 09 Crypto Assets)